Search

Resonance to raise $3m at two cents per share

Claremont based healthcare company Resonance Health Ltd today announced a deeply discounted $3.06 million entitlements offer at two cents per share to fund further development of FibroScreen, a non-invasive liver fibrosis test using magnetic resonance imaging.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/06/18

1 year TSR5 year TSR
134thDubber Corporation96%13%
285thrent.com.au30%-18%
404thResonance Health7%20%
701stOBJ-42%23%
749thConnected IO-54%62%
722 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

29/05/18
$2k Bought
23/05/18
$4k Bought
07/03/18
$5k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

117th↓Resonance Health$2.5m
128th↑Dubber Corporation$1.9m
129th↑Connected IO$1.9m
131st↓OBJ$1.8m
132nd↑rent.com.au$1.7m
239 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Resonance Health

1117thMartin Blake$60k
1265thSimon Panton$40k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer